Unfortunately, his signature legislation coupled with the Food and Drug Administration's confusing and somewhat disjointed approval process has instead encouraged the off-shoring of business and brought medical discoveries to a halt.
Linking FDA processes and legislation to negative impacts on medical innovation.
Share
More from Michael Burgess
I thank the gentleman for yielding additional time. However, one-sided pressure by the White House is not the way to ensure that end. Mr. Speaker, I urge passage of this rule from our committee, and I urge passage of the underlying…
I urge adoption of the amendment. It is important, with $31 trillion in national debt, that we be good stewards of taxpayer dollars. The gentleman is right. I have pursued this for a number of years, but it is because it is a noble cause…
This is a national emergency. This is something we have got to address and save Americans, 200 every day.
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
Other voices in this conversation
